---

Evolution of mucormycosis – Systematic review and meta-analysis

---

Review Article

Author Details : Karthikeyan Padmanabhan*, Kirubhagaran Ravichandran, Subhathra Radhakrishnan

Volume : 9, Issue : 4, Year : 2023

Article Page : 112-116

https://doi.org/10.18231/j.ijashnb.2023.024

Suggest article by email

Get Permission

---

Abstract

The outbreak of COVID-19, caused by the novel coronavirus SARS-CoV-2, has been linked to a notable rise in mucormycosis cases, particularly evident during the second wave in the summer of 2021. Mucormycosis, characterized by its aggressive nature and high mortality rates, requires rapid identification and intervention. Factors such as poorly controlled blood sugar levels, corticosteroid usage, and COVID-19-related immune compromise are significant contributors to its development. The objective of this review is to analyze the incidence, progression, clinical manifestations, and treatment approaches of mucormycosis, drawing from a selection of 16 pertinent articles published between 2009 and 2022, and accessed through databases like PubMed and Google Scholar.
 

Keywords: Mucormycosis, Invasive fungal infection, COVID­19, Immunocompromised patient, Liposomal

How to cite : Padmanabhan K, Ravichandran K, Radhakrishnan S, Evolution of mucormycosis – Systematic review and meta-analysis. IP Indian J Anat Surg Head Neck Brain 2023;9(4):112-116

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.